Academic Article RDF

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...

• 11-beta dehydrogenase type 2 activity is not reduced in treatment resistant hypertension
• 112 “BAND AND LEAVE” STRATEGY: A CASE SERIES COMPARISON OF BANDING VS. ENDOSCOPIC RESECTION FOR MANAGEMENT OF SMALL DUODENAL CARCINOID
• 1120 Assessment of Risk Factors for Mortality With TIPS Placement: Age or Frailty
• 114 Treatment of Bifurcation Aneurysms Using Single Stent-Coiling With Relation to Aneurysm Configuration: A Cohort Study of Two Academic Institutions in the United States.
• 1159 – Reliability of Videoconferencing Pathology in the Interpretation of Barrett's Esophagus
• 116 Gastrointestinal Bleeding Risk in Patients with Ventricular Assist Devices
• 119
• 11β-Hydroxyandrostenedione and δ⁵-androstenediol as markers of adrenal androgen production in patients with 21-hydroxylase-deficient nonclassic adrenal hyperplasia
• 11β-Hydroxysteroid dehydrogenases control access of 7β,27-dihydroxycholesterol to retinoid-related orphan receptor γ
• 12 Intensive care
• 12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels
• 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension the SYMPLICITY HTN-3 trial
• 12/15-Lipoxygenase-dependent ROS production is required for diet-induced endothelial barrier dysfunction
• 13-cis-retinoic acid competitively inhibits 3α-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: A mechanism for its anti-androgenic effects in sebaceous glands?
• 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study
• 130 IN VIVO ANALYSIS OF THE ADENOVIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSE IN CD28-, FASL-, AND PERFORIN-DEFICIENT MICE.
• 13109 Phosphorylation state of Myristoylated Alanine-Rich C-Kinase Substrate Effector Domain mimetics determines its cytotoxicity in glioblastoma and macrophage model
• 133-Xe inhalation method: rCBF indices for total volume flow, normalized flow rate, and tissue volume perfused in acute stroke compared with findings of computer-assisted tomography.
• 136 NOVA primary results randomised controlled study of natalizumab Q6W versus continued Q4W treatment for MS
• 1394
• 1396
• 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease
• 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
• 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
• 14-3-3 proteins play a role in the cell cycle by shielding Cdt2 from ubiquitin-mediated degradation
• 14-3-3 proteins protect AMPK-phosphorylated ten-eleven translocation-2 (TET2) from PP2A-mediated dephosphorylation
• 14-3-3 proteins reduce cell-to-cell transfer and propagation of pathogenic α-synuclein
• 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening
• 14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases
• 14-3-3theta protects against neurotoxicity in a cellular parkinson's disease model through inhibition of the apoptotic factor Bax

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...